drug
BETAMETHASONE DIPROPIONATE
Marketedupdated 5mo agoby Perrigo New York Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4indications
investigational
Psoriasis
all catalysts(1)
Trials studying BETAMETHASONE DIPROPIONATE
- phase3Comparison of Post-Inflammatory Pigment Alteration After Psoriasis Treatment (PIPA - Dermavant)
- phase2Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris
- phase3LEO 90105 Ointment in Japanese Subjects With Psoriasis
- phase2A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination Products
- phase2A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris
- phase3Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis
- phase3Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis
- phase1A Vasoconstriction Study With LEO 90100
Patent cliff
source: FDA Orange Bookfirst barrier falls
Aug 31, 2030
~3.9 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (7)
- Aug 31, 2030formulationUS 101791373.9y
- Aug 31, 2030formulationUS 93644853.9y
- Aug 31, 2030formulationUS 94336303.9y
- Aug 31, 2030formulationUS 94399113.9y
- Aug 31, 2030formulationUS 96559073.9y
- Aug 31, 2030formulationUS 97758513.9y
- Aug 31, 2030formulationUS 98779743.9y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that